Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASPOFUNGIN vs CEFEPIME\CEFEPIME: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CASPOFUNGIN vs CEFEPIME\CEFEPIME: Safety Overview

Metric CASPOFUNGIN CEFEPIME\CEFEPIME
Total FAERS Reports 3,814 162
Deaths Reported 1,419 31
Death Rate 37.2% 19.1%
Hospitalizations 1,638 64
Average Patient Age 47.5 yrs 54.5 yrs
% Female Patients 42.8% 43.9%
FDA Approval Date Dec 30, 2016 N/A
Manufacturer Sandoz Inc N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A